A hereditary moyamoya syndrome with multisystemic manifestations

Neurology

Volumn 75, Issue 3, 2010, Pages 259-264

  Herve D ^a   Touraine, P ^e   Verloes, A ^g   Miskinyte, S ^h   Krivosic, V ^b   Logeart, D ^c   Alili, N ^a   Laredo, J D ⁱ   Gaudric, A ^j   Houdart, E ^d   Metzger, J P ^f   Tournier Lasserve, E ^a,h   Woimant, F ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b Service d'Ophtalmologie   (France)

^c Hôpita Boucicaut   (France)

^d Service de Neuroradiologie   (France)

^e Service d'Endocrinologie et Médecine de la Reproduction   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

^h INSERM   (France)

ⁱ HopitaI Lariboisiere   (France)

^j UNIVERSITÉ PARIS DESCARTES   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HEMOGLOBIN; SEX HORMONE;

ADULT; ALGERIA; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AZOOSPERMIA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CATARACT; CHILD; CHROMOSOME 10; CHROMOSOME 17; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FACE DYSMORPHIA; FAMILY; FAMILY HISTORY; GENE LOCUS; GENETIC LINKAGE; GROWTH HORMONE DEFICIENCY; HAIR COLOR; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; HYPERGONADOTROPIC HYPOGONADISM; IMMUNOHISTOCHEMISTRY; INTERNAL CAROTID ARTERY OCCLUSION; KARYOTYPING; LABORATORY TEST; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOYAMOYA DISEASE; MUSCLE BIOPSY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PERINATAL PERIOD; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; SHORT STATURE;

EID: 77954980222     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181e8ee3f     Document Type: Article

References (24)

1. Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol 2008;7:1056-1066.
2. Kuriyama S, Kusaka Y, Fujimura M, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke 2008;39:42-47.
3. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000;15:179-182.
4. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999;64:533-537.
5. Yamauchi T, Tada M, Houkin K, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000;31:930-935.
6. Sakurai K, Horiuchi Y, Ikeda H, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 2004;49:278-281.
7. Mineharu Y, Liu W, Inoue K, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 2008;70:2357-2363.
8. Jea A, Smith ER, Robertson R, Scott RM. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics 2005;116:e694-e701.
9. Hankinson TC, Bohman LE, Heyer G, et al. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarterio-synangiosis. J Neurosurg Pediatr 2008;1:211-216.
10. Rosser TL, Vezina G, Packer RJ. Cerebrovascular abnormalities in a population of children with neurofibromato-sis type 1. Neurology 2005;64:553-555.
11. Guo DC, Papke CL, Tran-Fadulu V, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet 2009;84:617-627.
12. Longo N, Schrijver I, Vogel H, et al. Progressive cerebral vascular degeneration with mitochondrial encephalopathy. Am J Med Genet A 2008;146:361-367.
13. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med 2009;360:1226-1237.
14. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980;62:1054-1061.
15. Matsumura Y, Elliott PM, Mahon NG, Virdee MS, Doi Y, McKenna WJ. Familial dilated cardiomyopathy: assessment of left ventricular systolic and diastolic function using Doppler tissue imaging in asymptomatic relatives with left ventricular enlargement. Heart 2006;92:405-406.
16. Mahon NG, Murphy RT, MacRae CA, Caforio AL, Elliott PM, McKenna WJ. Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomy-opathy reveals preclinical disease. Ann Intern Med 2005; 143:108-115.
17. Stewart PM, Corrie J, Seckl JR, Edwards CR, Padfield PL. A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet 1988;1:1208-1210.
18. Report and recommendation N. 58 of the National Ethics Advisory Committee for the Life Sciences and Health (CCNE): Informed consent of and information to persons accepting care or research procedures. Paris, France: CCNE; 1998.
19. Lin TJ, Hwang FC, Chiu WT, Lin JW, Tsai SH, Chang CK. Empty sella, hypogonadism and hypopituitarism secondary to moyamoya disease. J Clin Neurosci 2005;12: 472-474.
20. MacKenzie CA, Milner RD, Bergvall U, Powell T. Growth failure secondary to moyamoya syndrome. Arch Dis Child 1990;65:232-233.
21. Kalina M, Kalina-Faska B, Wojaczynska-Stanek K, Malecka-Tendera E, Marszal E. Growth hormone deficiency associated with moyamoya disease in a 16-year-old boy. Hormones (Athens) 2004;3:204-207.
22. Gursoy A, Sahin M, Ertugrul DT, et al. Familial dilated cardiomyopathy hypergonadotrophic hypogonadism associated with thyroid hemiagenesis. Am J Med Genet A 2006;140:895-896.
23. Francis PJ, Berry V, Hardcastle AJ, Maher ER, Moore AT, Bhattacharya SS. A locus for isolated cataract on human Xp. J Med Genet 2002;39:105-109.
24. Coccia M, Brooks SP, Webb TR, et al. X-linked cataract and Nance-Horan syndrome are allelic disorders. Hum Mol Genet 2009;18:2643-2655.